Figure 3.

Mean annualized pharmaceutical spending and counts of monthly prescriptions for antidementia and antipsychotic drugs per patient diagnosed with Alzheimer’s disease or other forms of dementia and no diagnosis of FDA-approved indications of antipsychotic drugs.

Note. (a) Mean annualized off-label spending for antipsychotic agents per patient, by type of dementia and year. (b) Mean annualized number of monthly prescriptions filled off-labelly for antipsychotic drugs per patient, by type of dementia and year. FDA = Food and Drug Administration.